Intervention Review

5-alpha-reductase inhibitors for prostate cancer prevention

  1. Timothy J Wilt1,*,
  2. Roderick MacDonald1,
  3. Karen Hagerty2,
  4. Paul Schellhammer3,
  5. Barnett S Kramer4

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 23 APR 2008

Assessed as up-to-date: 14 FEB 2008

DOI: 10.1002/14651858.CD007091

How to Cite

Wilt TJ, MacDonald R, Hagerty K, Schellhammer P, Kramer BS. 5-alpha-reductase inhibitors for prostate cancer prevention. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007091. DOI: 10.1002/14651858.CD007091.

Author Information

  1. 1

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

  2. 2

    American Society of Clinical Oncology, Clinical Affairs, Alexandria, Virginia, USA

  3. 3

    Eastern Virginia Medical School, Deoartment of Urology, Norfolk, Virginia, USA

  4. 4

    National Institutes of Health, Bethesda, Maryland, USA

*Timothy J Wilt, General Internal Medicine (111-0), VAMC, One Veterans Drive, Minneapolis, Minnesota, 55417, USA.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 APR 2008


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.